136 related articles for article (PubMed ID: 33764655)
1. Cytotoxicity of mesoporous silica modified by amino and carboxyl groups on vascular endothelial cells.
Zhao J; Bu DY; Zhang N; Tian DN; Ma LY; Yang HF
Environ Toxicol; 2021 Jul; 36(7):1422-1433. PubMed ID: 33764655
[TBL] [Abstract][Full Text] [Related]
2. Toxicity evaluation of mesoporous silica particles Santa Barbara No. 15 amorphous in human umbilical vein endothelial cells: influence of particle morphology.
Teng W; Yang Z; Wang S; Xiong D; Chen Y; Wu Z
J Appl Toxicol; 2021 Sep; 41(9):1467-1478. PubMed ID: 33438233
[TBL] [Abstract][Full Text] [Related]
3. A Biodegradation Study of SBA-15 Microparticles in Simulated Body Fluid and in Vivo.
Choi Y; Lee JE; Lee JH; Jeong JH; Kim J
Langmuir; 2015 Jun; 31(23):6457-62. PubMed ID: 26013363
[TBL] [Abstract][Full Text] [Related]
4. Preparation of efficient quercetin delivery system on Zn-modified mesoporous SBA-15 silica carrier.
Trendafilova I; Szegedi A; Mihály J; Momekov G; Lihareva N; Popova M
Mater Sci Eng C Mater Biol Appl; 2017 Apr; 73():285-292. PubMed ID: 28183610
[TBL] [Abstract][Full Text] [Related]
5. Modifying release of poorly soluble active pharmaceutical ingredients with the amine functionalized SBA-16 type mesoporous materials.
Jadach B; Feliczak-Guzik A; Nowak I; Milanowski B; Piotrowska-Kempisty H; Murias M; Lulek J
J Biomater Appl; 2019 Apr; 33(9):1214-1231. PubMed ID: 30791849
[TBL] [Abstract][Full Text] [Related]
6. Preparation and characterization of tamoxifen loaded silica and NH2 functionalized mesoporous silica nanoparticles as delivery systems against MCF-7 breast cancer cells.
Taghavi S; Shahnani M; Rafati H
Iran J Basic Med Sci; 2023; 26(11):1334-1341. PubMed ID: 37885996
[TBL] [Abstract][Full Text] [Related]
7. pH-sensitive release of insulin-loaded mesoporous silica particles and its coordination mechanism.
Jiang F; Liu Y; Wang X; Yin Z
Eur J Pharm Sci; 2018 Jul; 119():1-12. PubMed ID: 29626595
[TBL] [Abstract][Full Text] [Related]
8. PLGA/SBA-15 mesoporous silica composite microparticles loaded with paclitaxel for local chemotherapy.
Nanaki S; Siafaka PI; Zachariadou D; Nerantzaki M; Giliopoulos DJ; Triantafyllidis KS; Kostoglou M; Nikolakaki E; Bikiaris DN
Eur J Pharm Sci; 2017 Mar; 99():32-44. PubMed ID: 27939620
[TBL] [Abstract][Full Text] [Related]
9. SBA-15- and SBA-16-Functionalized Silicas as New Carriers of Niacinamide.
Wawrzyńczak A; Nowak I; Feliczak-Guzik A
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139403
[TBL] [Abstract][Full Text] [Related]
10. Antitumor potential of cisplatin loaded into SBA-15 mesoporous silica nanoparticles against B16F1 melanoma cells: in vitro and in vivo studies.
Drača D; Edeler D; Saoud M; Dojčinović B; Dunđerović D; Đmura G; Maksimović-Ivanić D; Mijatović S; Kaluđerović GN
J Inorg Biochem; 2021 Apr; 217():111383. PubMed ID: 33582397
[TBL] [Abstract][Full Text] [Related]
11. Carboxylic modified spherical mesoporous silicas аs drug delivery carriers.
Popova MD; Szegedi Á; Kolev IN; Mihály J; Tzankov BS; Momekov GT; Lambov NG; Yoncheva KP
Int J Pharm; 2012 Oct; 436(1-2):778-85. PubMed ID: 22884833
[TBL] [Abstract][Full Text] [Related]
12. Adsorption and release of ampicillin antibiotic from ordered mesoporous silica.
Nairi V; Medda L; Monduzzi M; Salis A
J Colloid Interface Sci; 2017 Jul; 497():217-225. PubMed ID: 28285049
[TBL] [Abstract][Full Text] [Related]
13. Delivery of [Ru(η
Edeler D; Arlt S; Petković V; Ludwig G; Drača D; Maksimović-Ivanić D; Mijatović S; Kaluđerović GN
J Inorg Biochem; 2018 Mar; 180():155-162. PubMed ID: 29288894
[TBL] [Abstract][Full Text] [Related]
14. Simple way to obtain pH-sensitive drug release from functional mesoporous silica materials.
Xiang D; Lin H; Guo W; Ma J; Cui L; Jiang J; Qu F
IET Nanobiotechnol; 2014 Dec; 8(4):179-83. PubMed ID: 25429494
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of functionalized mesoporous silica SBA-15 as a carrier system for Ph
Bensing C; Mojić M; Gómez-Ruiz S; Carralero S; Dojčinović B; Maksimović-Ivanić D; Mijatović S; Kaluđerović GN
Dalton Trans; 2016 Dec; 45(47):18984-18993. PubMed ID: 27847952
[TBL] [Abstract][Full Text] [Related]
16. 2-Mercaptothiazoline modified mesoporous silica for mercury removal from aqueous media.
Pérez-Quintanilla D; del Hierro I; Fajardo M; Sierra I
J Hazard Mater; 2006 Jun; 134(1-3):245-56. PubMed ID: 16326000
[TBL] [Abstract][Full Text] [Related]
17. Adsorption of lysozyme on hyaluronic acid functionalized SBA-15 mesoporous silica: a possible bioadhesive depot system.
Medda L; Casula MF; Monduzzi M; Salis A
Langmuir; 2014 Nov; 30(43):12996-3004. PubMed ID: 25295387
[TBL] [Abstract][Full Text] [Related]
18. Supersaturation Potential of Ordered Mesoporous Silica Delivery Systems. Part 1: Dissolution Performance and Drug Membrane Transport Rates.
Dening TJ; Taylor LS
Mol Pharm; 2018 Aug; 15(8):3489-3501. PubMed ID: 29985627
[TBL] [Abstract][Full Text] [Related]
19. Dissolution enhancement of a model poorly water-soluble drug, atorvastatin, with ordered mesoporous silica: comparison of MSF with SBA-15 as drug carriers.
Maleki A; Hamidi M
Expert Opin Drug Deliv; 2016; 13(2):171-81. PubMed ID: 26636904
[TBL] [Abstract][Full Text] [Related]
20. Antioxidant properties of probucol released from mesoporous silica.
Lau M; Giri K; Garcia-Bennett AE
Eur J Pharm Sci; 2019 Oct; 138():105038. PubMed ID: 31398394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
